Search alternatives:
barriers decrease » larger decrease (Expand Search)
barrier disease » barrier discharge (Expand Search)
significant co » significant _ (Expand Search), significant gap (Expand Search), significant factor (Expand Search)
co decrease » _ decrease (Expand Search), a decrease (Expand Search), nn decrease (Expand Search)
barriers decrease » larger decrease (Expand Search)
barrier disease » barrier discharge (Expand Search)
significant co » significant _ (Expand Search), significant gap (Expand Search), significant factor (Expand Search)
co decrease » _ decrease (Expand Search), a decrease (Expand Search), nn decrease (Expand Search)
-
1
-
2
Crossing Barriers<i>: In Vitro</i> Cancer Model for Studying Monocyte Migration across Endothelial Barriers
Published 2025“…Inflammatory cytokines, such as granulocyte–macrophage colony-stimulating factor (GM-CSF), interleukin-6 (IL-6), interleukin-10 (IL-10), and interleukin-1β (IL-1β) secretion levels increased, while tumor necrosis factor α (TNF-α) and interleukin-12p40 (IL-12p40) levels decreased and monocyte chemoattractant protein-1 (MCP-1) and interleukin-8 (IL-8) levels remained unchanged in the presence of the EC barrier and spheroids, confirming the importance of the EC barrier for monocyte activation and migration. …”
-
3
Crossing Barriers<i>: In Vitro</i> Cancer Model for Studying Monocyte Migration across Endothelial Barriers
Published 2025“…Inflammatory cytokines, such as granulocyte–macrophage colony-stimulating factor (GM-CSF), interleukin-6 (IL-6), interleukin-10 (IL-10), and interleukin-1β (IL-1β) secretion levels increased, while tumor necrosis factor α (TNF-α) and interleukin-12p40 (IL-12p40) levels decreased and monocyte chemoattractant protein-1 (MCP-1) and interleukin-8 (IL-8) levels remained unchanged in the presence of the EC barrier and spheroids, confirming the importance of the EC barrier for monocyte activation and migration. …”
-
4
Crossing Barriers<i>: In Vitro</i> Cancer Model for Studying Monocyte Migration across Endothelial Barriers
Published 2025“…Inflammatory cytokines, such as granulocyte–macrophage colony-stimulating factor (GM-CSF), interleukin-6 (IL-6), interleukin-10 (IL-10), and interleukin-1β (IL-1β) secretion levels increased, while tumor necrosis factor α (TNF-α) and interleukin-12p40 (IL-12p40) levels decreased and monocyte chemoattractant protein-1 (MCP-1) and interleukin-8 (IL-8) levels remained unchanged in the presence of the EC barrier and spheroids, confirming the importance of the EC barrier for monocyte activation and migration. …”
-
5
-
6
-
7
-
8
-
9
-
10
-
11
-
12
Local consumer escalation process (adapted from Local Health Network (CALHN) procedure 2019) [16].
Published 2025Subjects: -
13
-
14
BA attenuated the decrease in the expression of ZO-1 and Occludin induced by LPS in Caco2 cells.
Published 2024Subjects: -
15
Apoptosis inhibitor abolished and restored rTsSPc-disrupted Caco-2 monolayer barrier integrity.
Published 2025Subjects: -
16
Recognizing the biological barriers and pathophysiological characteristics of the gastrointestinal tract for the design and application of nanotherapeutics
Published 2024“…Therapeutics for GIT disease treatment face multiple biological barriers, which significantly decrease the efficacy of therapeutics. …”
-
17
-
18
-
19
CKO mice display decreased skin barrier function and perturbed homeostasis.
Published 2025Subjects: -
20